Accessed 11 Jan 2018
doi.org/10.1001/jamaophthalmol.2024.6058
Many have advocated that the associations between low mood, suicidal behavior and anti-obesity drugs such as GLP-1RAs are confounded by the pre-existing higher prevalence of neuropsychiatric disorders observed in people living with obesity compared with the general population 236
The ready-to-use format is convenient and helps streamline routine bench work, particularly when several projects are being handled in parallel
Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, Levine MA, Schwindinger W, and Bernier M
In 2022, tirzepatide was launched, becoming the worlds first new-generation drug that acts on both GLP-1R/GIPR targets